S.No |
Name of the API |
Pharmacopeia Status |
1. |
Bendamustine Hydrochloride |
USP |
2. |
Bortezomib |
USP |
3. |
Capecitabine |
USP/Ph.Eur |
4. |
Dasatinib |
In-house |
5. |
Erlotinib Hydrochloride |
In- house |
6. |
Gemcitabine Hydrochloride |
USP/Ph.Eur |
7. |
Imatinib Mesylate |
IP |
8. |
Methotrexate |
IP |
9. |
Abirateron Acetate |
IP/USP |
10. |
Carmustine |
USP/EP |
11. |
Lapatinib di tosylate |
IP/IHS |
12. |
Lenalidomide |
IHS |
13. |
Sorafenib Tosylate |
IP/IHS |
14. |
Sunitinib Maleate |
IHS |
15. |
Temozolamide |
USP/ |